Coronary revascularization has matured as a field since coronary artery bypass grafting (CABG) was first developed over 50 years ago, with diagnostic and treatment methods having advanced dramatically. CABG remains the standard of care for obstructive disease, particularly patients multivessel disease or diabetes. It is now recognized that not all created equal—operative strategy, including con...

BACKGROUND Patients with prior CABG with a subsequent non-ST-segment elevation acute coronary syndrome (ACS) pose an increasingly important clinical problem. Although GP IIb/IIIa inhibitors have improved the outcome of patients with ACS, their efficacy in patients with prior CABG has not been previously evaluated. Methods and Results- We analyzed the 30- and 180-day outcomes of patients with pr...

Unfortunately, venous bypass grafts still have a prominent role in operative coronary revascularization (coronary artery bypass graft [CABG]). Venous grafts develop pathologically occlusive disease that limits the effectiveness of CABG, and antiplatelet drugs following operation may limit this problem. The types and indications of antiplatelet drugs following CABG generate some controversy in t...

OBJECTIVES More elderly patients (>80 years of age) are being referred for aortic valve replacement (AVR) with or without CABG. Current risk stratification models may not accurately predict the preoperative risk in these patients. We sought to determine which perioperative variables were relevant in determining short-term (30-day to in-hospital) outcomes in our intuition's series of consecutive...

BACKGROUND While early extubation after coronary artery bypass grafting (CABG) has been associated with resource savings, its effect on patient outcomes remains unclear. The goal of the present investigation was to evaluate whether early extubation can be performed safely in elderly CABG patients in community practice. METHODS We studied 6,446 CABG patients, aged 65 years and older, treated a...

Method This retrospective study was based on data from 183 patients who underwent CABG between January, 2000 and December, 2005. OPCAB was performed in 102 patients and c-CABG in 81. The mean follow-up duration was 107 months. The end-points of long-term results were overall death, freedom from cardiac death and major adverse cardiac events (MACE). We expressed the Kaplan-Meyer survival curve, ...

BACKGROUND Coronary artery bypass grafting (CABG) is often used to treat patients with significant coronary heart disease (CHD). To date, multiple longitudinal and cross-sectional studies have examined the association between depression and CABG outcomes. Although this relationship is well established, the mechanism underlying this relationship remains unclear. The purpose of this study was two...

Secondary coronary revascularizations can be required due to the progression of artery lesions and degeneration bypass grafts in long term after initial graft (CABG) surgery. It is therefore necessary clarify clinical characteristics these patients how improve their prognosis. Optimal medical treatments, including medications, smoking cessation, cardiac rehabilitation, are essential baseline ma...

PURPOSES The aim of this retrospective study was to investigate the effect of chronic kidney disease (CKD) on outcomes after coronary artery bypass grafting (CABG), and to determine whether preoperative estimated glomerular filtration rate (eGFR) can be a predictor of long-term outcomes after CABG. METHODS 486 Japanese patients who underwent isolated CABG between December 2000 and August 2010...

from a creatine kinase-based enzyme rise to a troponin-based rise. Use of beta-blockers in patients with left ventricular (LV) impairment is also strongly supported by numerous controlled trials, and these patients should certainly receive beta-blockers post-CABG. We agree that use of beta-blockers in patients without prior MI (ST-segment or non–ST-segment elevation) or LV impairment is more de...